Evidence map›Paper›PMID 33823976›Full record

ArticleJournal of studies on alcohol and drugs2021

Cannabis Marketing and Problematic Cannabis Use Among Adolescents.

Pamela J Trangenstein, Jennifer M Whitehill, Marina C Jenkins, David H Jernigan, Megan A Moreno

Open access · greenAbstract read
In one paragraph

Article in Journal of studies on alcohol and drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Local Cannabis Policy and Cannabis Use by California High School Students Before and After Statewide Retail Legalization.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2026
    Article
  7. Article
  8. Article
  9. Developing an online cannabis store paradigm for Cannabis Regulatory Science.medRxiv : the preprint server for health sciences · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Research and Clinical Practice Involving the Use ofPharmaceuticals (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Pamela J TrangensteinDepartment of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Jennifer M WhitehillDepartment of Health Promotion and Policy, University of Massachusetts Amherst School of Public Health and Health Sciences, Amherst, Massachusetts.
Marina C JenkinsDepartment of Pediatrics, University of Wisconsin - Madison School of Medicine and Public Health, Madison, Wisconsin.
David H JerniganDepartment of Health Law, Policy, and Management, Boston University School of Public Health, Boston, Massachusetts.
Megan A MorenoDepartment of Pediatrics, University of Wisconsin - Madison School of Medicine and Public Health, Madison, Wisconsin.
University of Wisconsin–Madison · USBoston University · USUniversity of Massachusetts Amherst · USUniversity of North Carolina at Chapel Hill · US

Funding

TREND &STRUCTURE OF ALCOHOL DEPENDENCE--GENERAL POPULATION 1990 SURVEY DATAP50AA005595 · NIAAA · WESTERN CONSORTIUM FOR PUBLIC HEALTH · PI MARTINEZ, PRISCILLA · 1985 to 2025
$34.1M
GRADUATE RESEARCH TRAINING ON ALCOHOL PROBLEMST32AA007240 · NIAAA · UNIVERSITY OF CALIFORNIA BERKELEY · PI William C. Kerr · 1985 to 2026
$7.5M
Marijuana ads in traditional and social media: Influence and policy implicationsR01DA041641 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI MORENO, MEGAN A. · 2017 to 2019
$1.2M
NIAAA NIH HHS P50 AA005595NIAAA NIH HHS T32 AA007240NIDA NIH HHS R01 DA041641
6 · The paper itself

Abstract

objectiveHealth consequences of commercializing nonmedical cannabis remain unclear, but data suggest that youth may encounter unintended risks. This study examined whether cannabis marketing exposure and engagement are associated with problematic cannabis use among adolescents.

methodThe analytic sample included 172 lifetime cannabis users (15-19 years old) who lived in one of six states with legalized nonmedical cannabis in 2018. Predictors included having exposure to or engagement with cannabis marketing on Facebook or Instagram, seeing cannabis billboards, owning/likely to own cannabis-branded merchandise, and reporting a favorite cannabis brand. Logistic regression assessed whether these predictors were associated with weekly cannabis use, high-intensity cannabis use, and cannabis use disorder (CUD).

resultsAdolescents who saw billboards rarely/sometimes had 5 times the odds of CUD, whereas youth who saw them most/all of the time had 7 times the odds of weekly use and 6 times the odds of CUD. Adolescents who owned/were likely to own branded merchandise had nearly 23 times the odds of weekly use, and those with a favorite brand had 3 times the odds of weekly use and CUD. Adolescents who reported seeing promotions on Instagram rarely/sometimes had 85% lower odds of weekly use, and those who saw them most/all of the time had 93% lower odds.

conclusionsThe ways cannabis businesses market their products, especially branding, may affect patterns of underage cannabis use. Future research should test whether these associations persist in longitudinal designs. In the interim, states should consider an approach that offers youth additional means to protect them from cannabis marketing.

Indexed as

MarketingAdolescentAdvertisingCommerceFemaleHumansLogistic ModelsMaleMarijuana AbuseMarijuana UseYoung Adult

Identifiers

PMID33823976
PMCPMC8864622
OpenAlexW3143366200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.